Amiodarone hydrochloride and Paranasal sinus hypersecretion - a phase IV clinical study of FDA data
Paranasal sinus hypersecretion is reported only by a few people who take Amiodarone Hydrochloride.
The phase IV clinical study analyzes which people take Amiodarone hydrochloride and have Paranasal sinus hypersecretion. It is created by eHealthMe based on reports of 6,115 people who have side effects while taking Amiodarone hydrochloride from the FDA, and is updated regularly.
With medical big data and AI algorithms, eHealthMe enables everyone to run phase IV clinical trial to detect adverse drug outcomes and monitor effectiveness. Our original studies have been referenced on 600+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Most recently, phase IV clinial trails for COVID 19 vaccines have been added, check here.
6,115 people reported to have side effects when taking Amiodarone hydrochloride.
Among them, 2 people (0.03%) have Paranasal sinus hypersecretion.
What is Amiodarone hydrochloride?
Amiodarone hydrochloride has active ingredients of amiodarone hydrochloride. It is often used in atrial fibrillation/flutter. eHealthMe is studying from 6,790 Amiodarone hydrochloride users for its effectiveness, alternative drugs and more.
What is Paranasal sinus hypersecretion?
Paranasal sinus hypersecretion is found to be associated with 645 drugs and 364 conditions by eHealthMe.
Number of Amiodarone hydrochloride and Paranasal sinus hypersecretion reports submitted per year:
Gender of people who have Paranasal sinus hypersecretion when taking Amiodarone hydrochloride *:
- female: 0.0 %
- male: 100 %
Age of people who have Paranasal sinus hypersecretion when taking Amiodarone hydrochloride *:
- 0-1: 0.0 %
- 2-9: 0.0 %
- 10-19: 0.0 %
- 20-29: 0.0 %
- 30-39: 0.0 %
- 40-49: 0.0 %
- 50-59: 0.0 %
- 60+: 100 %
Common drugs people take besides Amiodarone hydrochloride *:
- Synthroid: 2 people, 100.00%
- Omeprazole: 2 people, 100.00%
- Lorazepam: 2 people, 100.00%
- Lipitor: 2 people, 100.00%
- Glipizide: 2 people, 100.00%
- Furosemide: 2 people, 100.00%
- Forteo: 2 people, 100.00%
- Coumadin: 2 people, 100.00%
- Celexa: 2 people, 100.00%
- Allopurinol: 2 people, 100.00%
Common side effects people have besides Paranasal sinus hypersecretion *:
- Rhinorrhea (watery mucus discharge from the nose): 2 people, 100.00%
- Insomnia (sleeplessness): 2 people, 100.00%
- Hypotension (abnormally low blood pressure): 2 people, 100.00%
- Hip Fracture: 2 people, 100.00%
- Heart Rate Irregular: 2 people, 100.00%
- Fall: 2 people, 100.00%
- Dizziness: 2 people, 100.00%
- Cough: 2 people, 100.00%
- Abdominal Distension: 2 people, 100.00%
Common conditions people have *:
- Osteoporosis (bones weak and more likely to break): 2 people, 100.00%
* Approximation only. Some reports may have incomplete information.
Do you take Amiodarone hydrochloride and have Paranasal sinus hypersecretion?Check whether Paranasal sinus hypersecretion is associated with a drug or a condition
How to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
Related publications that referenced our studies
- Tesic D, Kostic M, Paunovic D, Jankovic SM, "Analysis of the cost–effectiveness of dronedarone versus amiodarone, propafenone, and sotalol in patients with atrial fibrillation: results for Serbia", Kardiologia Polska (Polish Heart Journal), 2016 Jan .
- Kim DJ, Lee SC, Park GS, Kim GJ, Hwang WT, Lee CS, Lee MH, Hahn DH, Koh HC, "Amiodarone Induced Multiorgan Toxicity in a Patient of Hypertrophic Cardiomyopathy With Atrial Fibrillation", Journal of the Korean Geriatrics Society, 2013 Dec .
Alternative drugs to, pros and cons of Amiodarone hydrochloride:
- Amiodarone hydrochloride (6,790 reports)
Paranasal sinus hypersecretion treatments and more:
- Paranasal sinus hypersecretion (3,854 reports)
COVID vaccines that are related to Paranasal sinus hypersecretion:
- Paranasal sinus hypersecretion in Moderna COVID Vaccine
- Paranasal sinus hypersecretion in Pfizer BioNTech Covid Vaccine
- Paranasal sinus hypersecretion in Johnson and Johnson Covid Vaccine
How severe was Paranasal sinus hypersecretion and when was it recovered:
Expand to all the drugs that have ingredients of amiodarone hydrochloride:
Common drugs associated with Paranasal sinus hypersecretion:
All the drugs that are associated with Paranasal sinus hypersecretion:
- Paranasal sinus hypersecretion (645 drugs)
Common conditions associated with Paranasal sinus hypersecretion:
All the conditions that are associated with Paranasal sinus hypersecretion:
- Paranasal sinus hypersecretion (364 conditions)
How the study uses the data?
The study uses data from the FDA. It is based on amiodarone hydrochloride (the active ingredients of Amiodarone hydrochloride) and Amiodarone hydrochloride (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.